Welcome to our dedicated page for GEW news (Ticker: GEW), a resource for investors and traders seeking the latest updates and insights on GEW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GEW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GEW's position in the market.
Cambria Investment Management has announced plans to launch the Cambria Global Equal Weight ETF (GEW) on NASDAQ, scheduled for September 25, 2025. The new ETF will offer equal-weighted exposure to global equities with an expense ratio of 0.25%.
A unique feature of this launch is the one-time opportunity for investors to participate in a Section 351 tax-deferred exchange, allowing them to contribute highly appreciated securities in exchange for GEW shares without triggering immediate capital gains taxes. This exchange window closes on September 3, 2025.
The fund will join Cambria's ETF family, which currently manages 18 ETFs with over $2.7 billion in assets under management. GEW follows previous successful launches of ENDW and TAX, both featuring the 351 structure in partnership with ETF Architect.
